Where does Invent Medical Group, s.r.o. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Invent Medical Group, s.r.o. ranks #29,122 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Invent Medical Group, s.r.o. hold?

Invent Medical Group, s.r.o. holds 9 US utility patents granted between 2022 and 2025, spanning 5 technology areas.

What is Invent Medical Group, s.r.o.'s Innovation Score?

Invent Medical Group, s.r.o. has an Innovation Score of 36.9 out of 100 (top 45% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Invent Medical Group, s.r.o. focus on?

Invent Medical Group, s.r.o.'s top technology area is B29L (Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles) with 1 patents, ranking #1,585 of 2,540 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Invent Medical Group, s.r.o.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Invent Medical Group, s.r.o..

What does claim depth mean for Invent Medical Group, s.r.o.'s patents?

Invent Medical Group, s.r.o.'s patents average 1.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Invent Medical Group, s.r.o. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Invent Medical Group, s.r.o.

USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B29L (Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Invent ranks #29,122 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 5 technology areas.

#29,122
of 49,997 US assignees by volume: Top 45%
by Innovation Score (36.9/100): 1.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R29122 · Foreign Corporation #29,122 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 9 grants
MID-PACK #29,122/49,997
PHOTO-FINISH Intex Recreation
CPC-NARROW B29L · 5 areas
INNOV-THIN 36.9/100
CLAIMS-SPARSE 1.7 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Intex Recreation Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Invent’s 36.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (22%) Velocity 20.0 pts (54%) Breadth 7.9 pts (21%) Claim depth 1.0 pts (3%)

Qualcomm Incorporated · highest

85
Invent Medical… · this assignee

37
3D Lighting… · lowest

7

What this shows Invent's Innovation Score is 36.9/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Invent?

Each dot is one of Invent’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Invent’s own 1.7 claims/patent is at or below the 14.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Invent vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Invent's grants concentrate

Invent Medical Group, s.r.o. is a focused PatentsView assignee: 5 CPC subclasses with 11.1% of grants classified under B29L (Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles). Peak complete grant year is 2022 (6 grants) versus a trough of 1 in 2023. By volume, Invent sits between Intex Recreation Corp. and Istituto Europeo di Oncologia S.r.l..

Invent's three-year grant acceleration

Invent Medical Group, s.r.o. shows 8 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Intex Recreation

9
Intraway R&D

9
Intrepid Brands

9
Intrinsic Therape…

9
Invisalert Soluti…

9
Iron Cross Automo…

9
Isofol Medical AB

9
Istituto Europeo…

9
Invent Medical Gr… ◀

9

What this shows Invent holds 9 patents at rank #29,116, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Invent

By rank, the assignees closest to #29,116 in granted patent volume.

Leaders in B29L (Indexing Scheme Associated With Subclass B29c)

Other assignees with the most granted patents in Invent's primary technology class.

Invent's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Invent Medical Group, s.r.o. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	6	66.7%
2023	1	11.1%
2024	1	11.1%
2025partial year	1	11.1%

Which technologies does Invent Medical Group, s.r.o. patent most?

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

G06F - Electric Digital Data Processing 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Invent Medical Group, s.r.o.'s patent record in context - here's where to go next.

Invent Medical Group, s.r.o.'s lead technology class is B29L (Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles), 11.1% of its portfolio - see every assignee active in that class. Explore B29L
Ranked #29,122 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Invent Medical Group, s.r.o. against Intex Recreation Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.